ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 45 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $161,000 | -42.5% | 40,000 | -38.5% | 0.00% | -42.9% |
| Q1 2019 | $280,000 | -25.1% | 65,000 | 0.0% | 0.01% | -56.2% |
| Q4 2018 | $374,000 | -60.6% | 65,000 | -7.1% | 0.02% | -36.0% |
| Q3 2018 | $949,000 | -0.1% | 70,000 | -12.5% | 0.02% | +8.7% |
| Q2 2018 | $950,000 | +5.8% | 80,000 | 0.0% | 0.02% | -17.9% |
| Q1 2018 | $898,000 | +34.4% | 80,000 | -20.0% | 0.03% | +64.7% |
| Q4 2017 | $668,000 | -19.2% | 100,000 | -1.0% | 0.02% | -45.2% |
| Q3 2017 | $827,000 | +82.6% | 101,000 | 0.0% | 0.03% | +63.2% |
| Q2 2017 | $453,000 | -25.2% | 101,000 | -8.2% | 0.02% | -20.8% |
| Q1 2017 | $606,000 | +35.9% | 110,000 | 0.0% | 0.02% | +9.1% |
| Q4 2016 | $446,000 | -1.1% | 110,000 | +71.9% | 0.02% | -21.4% |
| Q3 2016 | $451,000 | -15.7% | 64,000 | -2.5% | 0.03% | -31.7% |
| Q2 2016 | $535,000 | -40.2% | 65,610 | -40.4% | 0.04% | +5.1% |
| Q1 2016 | $894,000 | -28.0% | 110,000 | +6.8% | 0.04% | -54.7% |
| Q4 2015 | $1,242,000 | -11.3% | 103,000 | -12.0% | 0.09% | +38.7% |
| Q3 2015 | $1,400,000 | -36.4% | 117,000 | -2.5% | 0.06% | -28.7% |
| Q2 2015 | $2,200,000 | – | 120,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |